Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs.
about
Pathophysiological Basis for the Formation of the Tumor MicroenvironmentLocalized in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reduction.The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma.Canine transmissible venereal tumour: a review.The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolism.Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation sizeModulation of the tumor vasculature and oxygenation to improve therapySR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumoursEffect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy.Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.Technetium-99m HMPAO and SPECT in the assessment of blood flow in human lung tumours.Tissue physiology and the response to heat.The effect of therapy on tumour vascular function.Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.Chemical modification of tumour blood flow.Tumour microcirculation as a target for hyperthermia.The effect of hydralazine dose on blood perfusion changes during hyperthermia.The use of hydralazine to manipulate tumour temperatures during hyperthermia.The effect of blood flow modification on intra- and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours.Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension.The potential for prazosin and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours.In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.A study of the mechanism of hydralazine enhancement of thermal damage in the KHT tumour.Regional hyperthermia for deep-seated malignancies using the BSD annular array.Exploring the therapeutic potential of vasoactive agents in tumors using a mathematical model.Folic acid-conjugated temperature and pH dual-responsive yolk/shell microspheres as a drug delivery system
P2860
Q26752406-E6D6B0DA-EA6C-45E6-B482-FE23D5D31C43Q31380209-C1A88D0A-EDEB-4A1D-BC23-3A0EFE8AFBEFQ33200054-4B1DECFF-4886-4113-9040-4AFA069AB271Q33335764-C71BA2BD-E61A-4AB1-9487-9E07F82C9FB7Q33587272-0D86D20F-FD79-4221-AD09-E6E27A8BC5ECQ34037963-B3875580-C33E-459F-8B49-4DFEABFC1366Q35538329-38DD8E4D-563F-4AEC-B0DB-12631304EEDCQ35804140-206F4997-9BB1-4CF2-9E32-B9706FC85DF7Q35920685-0BCF6EF6-E3A0-482F-AE26-4FCB490F8C27Q35976983-1DB1447D-8700-4B6E-AF64-644106F1F326Q36081731-0A16EE53-E465-42D5-A1CD-A5538FA6EABBQ36291879-1F4FF353-4A74-4882-9909-09DC7116D085Q36466603-1B1A6C91-AA4A-4E7A-9504-BAE37A652C1CQ36466953-D6E15344-BC87-4000-81A6-6A17C8E51004Q36497614-55500BC5-B3F4-452F-8D55-C87ABE066683Q36508953-B3A58C59-ECCB-464E-A267-7CC5CE2C45DBQ36707375-A8CF5C99-2D62-4067-9F01-7E4555FFE9CFQ39648583-4A969349-323E-475D-8CFE-8C8465951566Q39752144-611D69E1-D721-4FD6-8933-DAA40CDA2078Q40785000-EC623EF3-5A20-401A-BF7D-9BC7F20CB68CQ41177100-06B0AE56-AC95-4933-AA85-EFA2B63FC090Q41840462-FEA8A159-5CA3-4322-9D95-FE87E1EA7C4EQ41959790-F39594E1-5EB6-4373-BF1F-8CD9B16644AEQ42022458-C87504EC-ACF6-4FD7-ACE5-843557694227Q42099607-4E8AB867-DFE9-45C9-B2C6-67D0BC4F18C5Q44968840-6449415B-ADEF-48F3-BAF3-D7333B0F8728Q50254201-764E03AA-EC87-4C9F-9EE2-ACE45B1820C8Q52447604-D9EA6575-B51D-4466-BF02-71102F745CC0Q57365147-AC238D3F-35CB-4E64-AE21-5FA417180F8C
P2860
Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs.
@en
type
label
Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs.
@en
prefLabel
Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs.
@en
P1476
Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs.
@en
P2093
Voorhees WD 3rd
P304
P356
10.1016/0277-5379(82)90252-8
P577
1982-10-01T00:00:00Z